←
Contrary Research2,507 posts
Contrary Research avatar

Contrary Research

@Contrary_Res

The best starting point for understanding private tech companies. Powered by @contrary. Subscribe to our newsletter below:

◷ Joined March 2022▧ 775 Photos and videos
Contrary Research avatar
Contrary Research@Contrary_Res·14 Sep 2022

We’re excited to introduce Contrary Research! Our vision is to be the best destination for finding high-quality research and in-depth analysis of private companies. 1/11

Post attachment
Contrary avatar
⟳ Contrary Research retweeted
Contrary@contrary·Aug 24

Contrary Venture Partner applications are now open! If you're a builder on campus, interested in investing in exceptional startups, and want to be part of one of the most selective communities in tech, apply now. Contrary invests and works directly alongside exceptional founders to build enduring companies, from seed to scale. With this approach, we’ve been fortunate to back iconic companies like Ramp, Anduril, Zepto, and many others. Our Venture Partners are great builders and future founders who become the go-to resource for others on campus. As a VP, you’ll learn first-hand what it takes to build and invest in exceptional companies, from taking part in investment decisions to sitting in on fireside chats with seasoned founders and investors. Best of all, you’ll be joining and learning from the best community in tech. Most VPs go on to become venture-backed founders, early engineers/operators, or investors, and enjoy the support of Contrary’s network for life. Read more here: contrary.com/blog/venture-pa… Apply here by Sept 13th: contrarycap.typeform.com/Con…

Post attachment
Kyle Harrison avatar
⟳ Contrary Research retweeted
Kyle Harrison@kwharrison13·Jun 8

There is no such thing as dying of old age. Age is a measure of how much the average "human system" can take. But all the things that cause our bodies to break down are solvable. It's just a matter of time. And immortality may have just entered clinical trials.

Contrary Research @Contrary_Res Jun 8 Article The Anti-Aging Therapeutics Boom In January 2026, the FDA cleared the first cell reprogramming therapeutic drug for human testing with the implicit goal of reversing aging. Specifically, the agency cleared ER-100, a therapy designed

Kyle Harrison avatar
⟳ Contrary Research retweeted
Kyle Harrison@kwharrison13·May 4

Sierra is an insane business because, despite countless companies trying to automate customer service, it remains an endlessly painful process. Going up against all of that baggage they're still managing to actually solve problems for some of the most customer-centric brands.

[NEW REPORT]: We've released an updated report outlining Sierra's business and how the company: • Reached $100M+ ARR in just under three years • Is powering hundreds of millions of interactions • Are building for a future with ChatGPT as a dominant consumer channel Plus... • How Sierra competes against incumbent giants like Salesforce's Agentforce, Genesys, and NICE; and why their distribution advantages may matter less than expected • The AI-native rivalry with Decagon, Ada, and PolyAI, and where each company is making different bets on orchestration, voice, and pricing • Why outcome-based pricing is more than a gimmick and how it structurally locks in expansion revenue in ways seat-based incumbents can't match • The "build once, run everywhere" architecture that lets a single agent operate consistently across phone, chat, SMS, email, and even ChatGPT • Inside the product stack: Agent SDK, Agent Studio, Ghostwriter, Insights 2.0, the Agent Data Platform, and Live Assist; and how they fit together as an operating system rather than a chatbot • The shift from cost center to revenue protection: How Sierra is moving beyond ticket deflection into churn saves, win-backs, and identity-gated upgrades where the value per resolution rises sharply • Market sizing across three converging pools: Conversational AI, contact-center software, and the $120B+ in U.S. customer service wages alone • The Bret Taylor founding story including the lunch with Clay Bavor where they decided to start a company with no product idea, only a conviction • Key risks that could derail the thesis, including how a single high-profile agent failure could reshape enterprise willingness to automate sensitive workflows • The international expansion playbook: SoftBank investment, the Opera Tech acquisition in Tokyo, and offices opening across Asia and Europe in under six months • What Sierra's valuation actually assumes about labor automation economics, and how it compares to compressing CCaaS multiples at Five9 and NICE

Post attachment